1. Kumagai T, Ota T, Tamura Y, Chang WX, Shibata S, Uchida S
    Time to target uric acid to retard CKD progression, Clin Exp Nephrol, in press, 2016
  2. Shibata S.(日本腎臓学会大島賞受賞論文)
    Context-dependent mechanisms modulating aldosterone signaling in the kidney. Clin Exp Nephrol, in press, 2016
  3. Taniguchi K, Tamura Y, Kumagai T, Shibata S, Uchida S
    Stimulation of V1a receptor increases renal uric acid clearance via urate transporters:Insight into pathogenesis of hypouricemia in SIADH. Clin Exp Nephrol , in press, 2016
  4. Nagura, M, Tamura Y, Kumagai T, Hosoyamada M, Uchida S
    Uric acid metabolism of kidney and intestine in a rat model of chronic kidney disease, Nucleosides Nucleotides Nucleic Acids, in press, 2016
  5. Hosoyamada M, Tsurumi Y, Hirano H, Tomioka N, Sekine Y, Morisaki T, Uchida S
    Urat1-Uox double knockout mice are experimental animal models of renal hypouricemia and exercise-induced acute kidney injury. Nucleosides Nucleotides Nucleic Acids, in press, 2016
  6. Kuribayashi-Okuma E, Shibata S, Arai S, Ota T, Watanabe S, Hisaki H, Okazaki T, Toda T, Uchida S.
    Proteomics approach identifies factors associated with the response to LDL apheresis therapy in patients with steroid-resistant nephrotic syndrome. , Ther Apher Dial, 20(2):174-182, 2016
  7. Chang WX, Arai S, Tamura Y, Kumagai T, Ota T, Shibata S, Fujigaki Y, Shen ZY, Uchida S
    Time-dependent risk factors associated with the decline of estimated GFR in CKD patients. Clin Exp Nephrol, 20(1):58-70, 2016
  8. Yamagata K, Makino H, Iseki K, Ito S, Kimura K, Kusano E, Shibata T, Tomita K, Narita I, Nishino T, Fujigaki Y, Mitarai T, Watanabe T, Wada T, Nakamura T, Matsuo S
    Study Group for Frontier of Renal Outcome Modifications in Japan(FROM-J). Effect of Behavior Modification on Outcome in Early- to Moderate-Stage Chronic Kidney Disease: A Cluster-Randomized Trial. PLOS ONE, 11(3):e0151422, 2016
  9. Higaki M, Tanemoto M, Shiraishi T, Taniguchi K, Fujigaki Y, Uchida S
    Acute Kidney Injury Facilitates Hypocalcemia by Exacerbating the Hyperphosphatemic Effect of Muscle Damage in Rhabdomyolysis., Nephron, 131(1):11-16, 2015
  10. Ono M, Sakao Y, Tsuji T, Ohashi N, Yasuda H, Nishiyama A, Fujigaki Y, Kato A
    Role of intrarenal(pro)renin receptor in ischemic acute kidney injury in rats, Clin Exp Nephrol, 19(2):185-196, 2015
  11. Isobe S, Ohashi N, Fujikura T, Tsuji T, Sakao Y, Yasuda H, Kato A, Miyajima H, Fujigaki Y
    Disturbed circadian rhythm of the intrarenal renin-angiotensin system: relevant to nocturnal hypertension and renal damage. Clin Exp Nephrol, 19(2):231-239, 2015
  12. Muso E, Mune M, Hirano T, Hattori M, Kimura K, Watanabe T, Yokoyama H, Sato H, Uchida S, Wada T, Shoji T, Takemura T, Yuzawa Y, Ogahara S, Sugiyama S, Iino Y, Sakai S, Ogura Y, Yukawa S, Nishizawa Y, Yorioka N, Imai E, Matsuo S, Saito T
    A Prospective Observational Survey on the Long-Term Effect of LDL Apheresis on Drug- Resistant Nephrotic Syndrome, Nephron Extra, 5(2):58- 66, 2015
  13. Tanemoto M, Higaki M, Amano K, Toyoki D, Arai S, Tomioka S, Uchida S
    Sonographic detection of a radiolucent object in dialysis vascular access. J Clin Ultrasound, 43(6):397-399, 2015
  14. Uchida S, Chang WX, Ota T, Tamura Y, Shiraishi T, Kumagai T, Shibata S, Fujigaki Y, Hosoyamada M, Kaneko K, Shen ZY, Fujimori S
    Targeting uric acid and the inhibition of progression to end-stage renal disease -A propensity score analysis., PLOS ONE, 10(12):e0145506, 2015
  15. Mera J, Okada E, Okuda M, Ota T, Sibata S, Uchida S
    Long-term efficacy of vildagliptin in patients with type 2 diabetes undergoing hemodialysis, J Diabetes Metab Disord, 5(14):83-83, 2015
  16. Ueda S, Ozawa S, Mori K, Asanuma K, Yanagita M, Uchida S, Nakagawa T
    ENOS deficiency causes podocyte injury with mitochondrial abnormality. Free Radic Biol Med,(87):181-192, 2015
  17. Chang WX, Asakawa S, Toyoki D, Nemoto Y, Morimoto C, Tamura Y, Ota T, Shibata S, Fujigaki Y, Shen ZY, Uchida S
    Predictors and the subsequent risk of end-stage renal disease –Usefulness of 30 % decline in estimated GFR over 2 years. PLOS ONE, 10(7):e0132927, 2015
  18. Kato H, Fujigaki Y, Asakawa S, Yamaguchi Y, Uozaki H, Komatsuda A, Nagata M, Uchida S
    Rapid Deterioration of the Renal Function Caused by the Coexistence of Intratubular Amyloidosis and Myeloma Cast Nephropathy. Intern Med, 54(23):3023-3028, 2015
  19. Kato H, Shiraishi T, Ueda S, Kubo E, Shima T, Nagura M, Yano H, Izumikawa Y, Shimada M, Tomioka S, Nosaka H, Kojima K, Tanemoto M, Uchida S
    Blood pressure control and satisfaction of hypertensive patients following a switch to combined drugs of an angiotensin receptor blocker and a calcium channel blocker in clinical practice of nephrology. Clin Exp Nephrol, 19(3):465-473, 2015
  20. Hayashi M, Uchida S, Kawamura T, Kuwahara M, Nangaku M, Iino Y
    PROTECT-CKD Study Group. Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study., Clin Exp Nephrol, 19(5):925-932, 2015
  21. Muso E, Mune M, Hirano T, Hattori M, Kimura K, Watanabe T, Yokoyama H, Sato H, Uchida S, Wada T, Shoji T, Yuzawa Y, Takemura T, Sugiyama S, Nishizawa Y, Ogahara S, Yorioka N, Sakai S, Ogura Y, Yukawa S, Iino Y, Imai E, Matsuo S, Saito T
    Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study. Clin Exp Nephrol, 19(3):379-386, 2015
  22. Asakawa S, Tanemoto M, Kawamorita Y, Okura R, Fujigaki Y, Uchida S
    Clinical Image. Lack of Blood Flow in Bilateral Renal Cortex, JSM Clin Case Rep, 2(5):1054- 1054, 2015
  23. 内田俊也
    CKD と高尿酸血症 その病態と治療 , 痛風と核酸代謝 , 39(2):113-120, 2015
  24. 内田俊也、常 文秀、田村好古
    CKD と高尿酸血症−その病態と治療− , 痛風と核酸代謝 , 39(2):168-168, 2015
  25. 内田俊也
    【CKD 患者の管理】尿酸管理 , 動脈硬化予防 , 14(4):45-51, 2015
  26. 柴 田 茂
    生活習慣病に対する漢方:腎臓疾患 , 成人病と生活習慣病 , 45(2):204-207, 2015
  27. 柴 田 茂
    腎臓におけるミネラルコルチコイド受容体の活性化機構 , 腎と透析 , 78(2):307-312, 2015
  28. 柴 田 茂
    腎臓におけるミネラロコルチコイド受容体の制御機構(第 37 回腎臓セミナー・Nexus Japan プロシーディング)(大島賞受賞講演), 日本腎臓学会誌 , 57(8):1327-1330, 2015
  29. 柴 田 茂
    腎臓による細胞外液調節のしくみと高血圧 , 実験医学 , 34(8):1245-1251, 2015
  30. 太田 樹、内田俊也
    【腎臓病と代謝障害−内科医に求められる基礎と応用−】水・ナトリウム代謝異常 , 日本内科学会雑誌 , 104(5):906-916, 2015
  31. 内田俊也、倉賀野隆裕、稲葉雅章、正井基之
    「カーボスター透析剤」によるアシドーシス補正から見た骨・Ca 代謝への影響(座談会), Pharma Medical, 33(6):49-56, 2015
  32. 久保英二、天野慶子、田村好古、加藤秀樹、太田 樹、木村佳貴、河野 肇、藤垣嘉秀、内田俊也
    トシリズマブが有効であった関節リウマチに合併したAA アミロイドーシスによる高度腎機能低下ネフローゼ症候群の 1 例(原著論文 / 症例報告), 腎と透析 , 78(6):950-954, 2015
  33. 小高健三、藤垣嘉秀、奈倉倫人、古西純子、田村好古、太田 樹、柴田 茂、内田俊也
    膜性腎症の先行が疑われた MPO-ANCA 関連腎炎の 1 例, 腎と透析 , 78(6):945-949, 2015
  34. 戸田晃央、前澤利光、村上容子、日野雅予、堀越亮子、斎藤 修、小林弘明
    在宅血液透析開始における問題点を地域連携により解決した経験(原著論文 / 症例報告), 茨城県立病院医学雑誌 , 31,(2):17-20, 2015
  35. 太田 樹、大倉理沙、谷口 敬、柴田 茂、藤垣嘉秀、内田俊也
    【要望演題:難病・がん患者に対する新たな治療・療養の支援】終末期患者に対する慢性血液透析療法の見合わせの経験と考察 , 板橋区医師会医学会誌 , 20:140-142, 2015
  36. 飯野靖彦、伊藤 宏、泉 並木、内田俊也
    【臓器浮腫・うっ血の病態とその治療法】各臓器での水分調節とその異常(座談会), Fluid Management Renaissance, 5,(2):99-106, 2015
  37. 熊谷天哲、内田俊也
    「病気について知りたい ! 臨床講座」77 浮腫 , Pharma Tribune, 7(5):5-12, 2015
  38. 内田俊也
    【高尿酸血症からアプローチする生活習慣病の治療】高尿酸血症と CKD 病態と治療 , 日本医事新報, 4787:26-32, 2016
  39. 細谷龍男、東 幸仁、内田俊也、菅野義彦
    【尿酸と心・腎・血管障害】(座談会 / 特集), Nephrology Frontier, 15(2):104-112, 2016